TER vs ALAB vs NXPI
161 measures in 16 categories, one definition each, computed from filings and market data.
ALAB77.1
Astera Labs, Inc. Common Stock
Technology · Semiconductors
$285.82 −5.35%$49.6B mkt cap
Score DNA
Price, rebased to 100 three years ago
TER ALAB NXPI · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | TER | ALAB | NXPI |
|---|---|---|---|
| Insider open-market buys, 180d | 0 | 0 | 0 |
| Insider $ bought, 180d | — | — | — |
| Congress purchases, 180d | 4 | 0 | 7 |
| Last Congress purchase | 2026-05-01 | — | 2026-09-17 |
| 13F net change in holders | +200 | +288 | +119 |
| ETFs adding shares, 30d | 1,350 | 1,002 | 685 |
| ETFs trimming, 30d | 1,170 | 683 | 413 |
| Net ETF funds, 30d | +180 | +319 | +272 |
Valuation
16 measures| Measure | TER | ALAB | NXPI |
|---|---|---|---|
| P/E (TTM) | 44.2x
41st
|
134.2x
92nd
|
19.4x
10th
|
| PEG (P/E ÷ 3-yr EPS CAGR) | 1.52
39th
|
— | 5.82
94th
|
| Price / sales | 11.4x
64th
|
41.3x
96th
|
4.4x
32nd
|
| Price / book | 14.8x
85th
|
28.7x
99th
|
5.1x
47th
|
| Price / tangible book | 25.8x
82nd
|
53.9x
90th
|
— |
| Price / free cash flow | 63.5x
57th
|
179.2x
94th
|
19.6x
11th
|
| Price / operating cash flow | 47.7x
62nd
|
147.7x
95th
|
18.5x
19th
|
| Enterprise value | $50.6B
79th
|
$48.3B
77th
|
$65.6B
81st
|
| EV / sales | 11.3x
64th
|
40.2x
97th
|
5.0x
37th
|
| EV / EBITDA | 34.8x
57th
|
144.7x
89th
|
13.4x
15th
|
| EV / EBIT | 37.4x
45th
|
150.1x
91st
|
15.9x
11th
|
| EV / free cash flow | 63.2x
57th
|
174.7x
93rd
|
22.2x
13th
|
| Earnings yield | 2.3%
72nd
|
0.7%
37th
|
5.1%
93rd
|
| FCF yield | 1.6%
59th
|
0.6%
32nd
|
5.1%
92nd
|
| Operating cash flow yield | 2.1%
52nd
|
0.7%
27th
|
5.4%
85th
|
| Graham number (per share) | $59.82
79th
|
$20.78
27th
|
$108.74
92nd
|
Profitability (TTM)
12 measures| Measure | TER | ALAB | NXPI |
|---|---|---|---|
| Gross margin | 59.2%
80th
|
75.1%
92nd
|
55.9%
71st
|
| EBITDA margin | 32.6%
77th
|
27.8%
70th
|
37.1%
84th
|
| Operating margin | 30.6%
87th
|
22.8%
75th
|
28.7%
80th
|
| EBIT margin | 30.3%
81st
|
26.8%
76th
|
31.2%
82nd
|
| Net margin | 25.8%
81st
|
30.7%
88th
|
22.6%
77th
|
| NOPAT margin | 26.4%
84th
|
26.1%
81st
|
23.0%
77th
|
| FCF margin | 17.9%
67th
|
23.0%
80th
|
22.4%
77th
|
| Operating cash flow margin | 23.9%
65th
|
27.9%
80th
|
23.7%
63rd
|
| R&D / revenue | 12.5%
31st
|
36.1%
85th
|
18.4%
52nd
|
| SG&A / revenue | 15.5%
53rd
|
16.2%
57th
|
8.7%
21st
|
| Stock comp / revenue | 0.4%
7th
|
16.2%
84th
|
3.3%
46th
|
| Effective tax rate | 13.7%
32nd
|
-14.7%
4th
|
19.6%
60th
|
Returns on capital
11 measures| Measure | TER | ALAB | NXPI |
|---|---|---|---|
| ROE (on average equity) | 36.7%
92nd
|
25.8%
81st
|
28.4%
84th
|
| ROA | 26.5%
92nd
|
23.1%
89th
|
11.5%
75th
|
| ROIC | 37.1%
88th
|
66.4%
95th
|
15.9%
64th
|
| ROCE | 35.5%
95th
|
18.2%
76th
|
18.0%
75th
|
| Return on tangible assets | 31.1%
92nd
|
20.1%
81st
|
15.9%
77th
|
| Cash ROIC (OCF / invested capital) | 33.5%
78th
|
71.0%
97th
|
16.3%
55th
|
| Gross profitability (GP / assets) | 53.8%
97th
|
46.8%
95th
|
27.6%
60th
|
| ROIC, 3-yr average | 22.7%
78th
|
— | 13.5%
65th
|
| ROIC, 5-yr average | 26.2%
70th
|
— | 16.8%
51st
|
| ROE, 5-yr average | 25.5%
84th
|
— | 29.7%
89th
|
| Incremental ROIC | 123.8%
87th
|
33.7%
65th
|
63.1%
77th
|
Growth
17 measures| Measure | TER | ALAB | NXPI |
|---|---|---|---|
| Revenue growth (TTM YoY) | 57.9%
88th
|
98.5%
96th
|
8.8%
32nd
|
| Revenue growth (QoQ) | 3.6%
11th
|
27.3%
84th
|
9.9%
39th
|
| Revenue CAGR, 3 yr | 16.0%
74th
|
— | 0.0%
37th
|
| Revenue CAGR, 5 yr | 5.3%
39th
|
— | 5.8%
44th
|
| Gross profit CAGR, 3 yr | 16.7%
73rd
|
— | -0.6%
41st
|
| Operating income CAGR, 3 yr | 29.4%
85th
|
— | 0.3%
52nd
|
| Net income growth (TTM YoY) | 145.2%
80th
|
268.9%
85th
|
38.5%
56th
|
| Net income CAGR, 3 yr | 27.2%
85th
|
— | 2.4%
54th
|
| EPS growth (TTM YoY) | 150.4%
80th
|
260.5%
85th
|
38.4%
54th
|
| EPS CAGR, 3 yr | 29.0%
87th
|
— | 3.3%
54th
|
| EPS CAGR, 5 yr | 7.4%
49th
|
— | 25.8%
76th
|
| FCF growth (TTM YoY) | 40.6%
63rd
|
31.5%
52nd
|
39.0%
59th
|
| FCF CAGR, 3 yr | 20.0%
71st
|
— | 5.7%
54th
|
| Operating cash flow CAGR, 3 yr | 19.9%
74th
|
— | -4.6%
32nd
|
| Book value CAGR, 3 yr | 13.8%
71st
|
— | 12.8%
69th
|
| Dividend CAGR, 3 yr | 1.8%
41st
|
— | 1.4%
37th
|
| Sustainable growth rate | 34.2%
90th
|
25.8%
83rd
|
18.6%
71st
|
Margin history & stability
7 measures| Measure | TER | ALAB | NXPI |
|---|---|---|---|
| Gross margin, 3-yr average | 58.5%
79th
|
76.1%
94th
|
55.6%
75th
|
| Operating margin, 3-yr average | 23.2%
77th
|
-15.3%
18th
|
27.3%
85th
|
| Net margin, 3-yr average | 20.2%
77th
|
-7.8%
27th
|
20.5%
79th
|
| FCF margin, 3-yr average | 18.6%
68th
|
26.6%
87th
|
23.1%
79th
|
| Revenue stability (0-1) | 0.10
14th
|
0.99
100th
|
0.53
44th
|
| Earnings stability (0-1) | 0.00
3rd
|
0.99
99th
|
0.44
61st
|
| Margin stability (0-1) | 0.98
96th
|
0.98
94th
|
0.96
78th
|
Liquidity (latest quarter)
7 measures| Measure | TER | ALAB | NXPI |
|---|---|---|---|
| Cash & short-term investments | $354.8M
32nd
|
$1.3B
67th
|
$3.2B
81st
|
| Net cash (− = net debt) | $254.7M
55th
|
$1.3B
87th
|
−$7.8B
3rd
|
| Working capital | $1.3B
59th
|
$1.5B
67th
|
$3.9B
80th
|
| Current ratio | 2.12
20th
|
10.05
91st
|
2.04
19th
|
| Quick ratio | 1.76
24th
|
9.36
92nd
|
1.36
17th
|
| Cash ratio (cash + ST investments / current liabilities) | 0.32
4th
|
7.63
92nd
|
0.86
20th
|
| Defensive interval (days) | 417 days
19th
|
838 days
53rd
|
458 days
24th
|
Leverage & solvency (latest quarter)
13 measures| Measure | TER | ALAB | NXPI |
|---|---|---|---|
| Total debt | $100.1M
39th
|
$0
0th
|
$11.0B
93rd
|
| Debt / equity | 0.03
21st
|
0.00
0th
|
0.96
89th
|
| Net debt / equity | −0.07
63rd
|
−0.73
5th
|
0.68
93rd
|
| Debt / assets | 2.0%
20th
|
0.0%
0th
|
41.2%
92nd
|
| Debt / capital | 2.8%
21st
|
0.0%
0th
|
49.1%
89th
|
| Debt / EBITDA | 0.07
15th
|
0.00
0th
|
2.24
66th
|
| Net debt / EBITDA | −0.18
62nd
|
−3.75
18th
|
1.58
89th
|
| Interest coverage (EBIT / interest) | 105.2x
83rd
|
— | 8.9x
44th
|
| Cash interest coverage | 82.9x
83rd
|
— | 6.8x
31st
|
| Debt payback (years of OCF) | 0.1 yrs
16th
|
0.0 yrs
0th
|
3.5 yrs
78th
|
| Liabilities / assets | 29.5%
47th
|
10.7%
9th
|
55.9%
88th
|
| IS credit model rating | AA+ | AA | A+ |
| Implied credit spread (bps) | 65
0th
|
80
19th
|
125
45th
|
Efficiency
11 measures| Measure | TER | ALAB | NXPI |
|---|---|---|---|
| Asset turnover | 1.03
96th
|
0.75
73rd
|
0.51
45th
|
| Fixed asset turnover | 6.12
65th
|
10.08
88th
|
4.65
49th
|
| Inventory turnover | 3.2
73rd
|
3.5
79th
|
2.4
34th
|
| Receivables turnover | 5.8
41st
|
11.1
92nd
|
11.2
93rd
|
| Days sales outstanding | 63 days
59th
|
33 days
8th
|
32 days
7th
|
| Days inventory outstanding | 113 days
27th
|
105 days
21st
|
154 days
66th
|
| Days payables outstanding | 56 days
65th
|
52 days
55th
|
59 days
72nd
|
| Cash conversion cycle (days) | 120 days
45th
|
86 days
17th
|
128 days
49th
|
| Capex / revenue | 5.9%
62nd
|
4.9%
54th
|
1.3%
7th
|
| Capex / depreciation | 2.61
89th
|
4.93
96th
|
0.22
7th
|
| Operating expense ratio | 26.8%
32nd
|
50.5%
77th
|
26.6%
30th
|
Cash flow & earnings quality
7 measures| Measure | TER | ALAB | NXPI |
|---|---|---|---|
| Operating cash flow / net income | 0.93
29th
|
0.91
27th
|
1.05
37th
|
| FCF / net income | 0.70
31st
|
0.75
38th
|
0.99
56th
|
| FCF / operating cash flow | 75.1%
51st
|
82.4%
63rd
|
94.4%
93rd
|
| Capex / operating cash flow | 24.9%
49th
|
17.6%
37th
|
5.5%
7th
|
| Accruals ratio | 2.0%
80th
|
2.1%
83rd
|
-0.6%
69th
|
| Sloan accruals ratio | 5.6%
56th
|
25.1%
79th
|
-0.5%
33rd
|
| Earnings quality score (0-1) | 0.75
15th
|
0.75
15th
|
1.00
77th
|
Scores & forensic checks
15 measures| Measure | TER | ALAB | NXPI |
|---|---|---|---|
| IS score | 79
91st
|
77
85th
|
74
77th
|
| IS profitability | 98
93rd
|
94
87th
|
85
80th
|
| IS growth | 80
85th
|
78
79th
|
66
42nd
|
| IS value | 40
72nd
|
36
45th
|
56
93rd
|
| IS momentum | 90
74th
|
89
73rd
|
84
62nd
|
| IS risk (safety) | 100
12th
|
100
12th
|
100
12th
|
| IS quality | 86
88th
|
80
72nd
|
82
76th
|
| IS balance sheet | 84
45th
|
92
72nd
|
67
25th
|
| IS earnings quality | 62
44th
|
70
73rd
|
84
99th
|
| IS cash flow | 76
77th
|
76
79th
|
73
73rd
|
| Piotroski F-score (0-9) | 6
43rd
|
4
9th
|
8
91st
|
| Altman Z-score | 31.0
83rd
|
258.9
100th
|
4.0
12th
|
| Beneish M-score | −1.15
86th
|
2.43
99th
|
−2.31
58th
|
| Ohlson O-score | −11.07
23rd
|
−14.21
5th
|
−8.63
64th
|
| IS credit score | 93
91st
|
89
72nd
|
76
48th
|
Size (TTM)
8 measures| Measure | TER | ALAB | NXPI |
|---|---|---|---|
| Market cap | $50.8B
79th
|
$49.6B
77th
|
$57.8B
80th
|
| Revenue | $4.5B
73rd
|
$1.2B
56th
|
$13.2B
84th
|
| EBITDA | $1.5B
77th
|
$334.0M
59th
|
$4.9B
85th
|
| Net income | $1.2B
83rd
|
$369.5M
68th
|
$3.0B
85th
|
| Free cash flow | $799.9M
77th
|
$276.7M
64th
|
$3.0B
85th
|
| Total assets | $4.9B
67th
|
$1.9B
45th
|
$26.7B
85th
|
| Shareholders' equity | $3.4B
67th
|
$1.7B
55th
|
$11.4B
81st
|
| Employees | 6,600
65th
|
756
19th
|
32,169
88th
|
Price performance
9 measures| Measure | TER | ALAB | NXPI |
|---|---|---|---|
| 1 day | −5.3% | −5.3% | −0.8% |
| 1 week | −19.3% | −16.5% | +0.8% |
| 1 month | −8.0% | −2.6% | +0.6% |
| 3 months | −2.6% | −7.5% | −14.2% |
| 6 months | −14.5% | +64.2% | +6.1% |
| Year to date | +56.8% | +59.2% | +3.6% |
| 1 year | +130.9% | +77.0% | +6.0% |
| 3 years, cumulative | +229.9% | — | +17.3% |
| 5 years, cumulative | +202.3% | — | +30.4% |
Technicals
4 measures| Measure | TER | ALAB | NXPI |
|---|---|---|---|
| RSI 14 | 33.1 | 37.4 | 47.5 |
| From 52-week high | −33.4% | −42.8% | −32.5% |
| From 52-week low | +139.7% | +192.0% | +25.9% |
| Beta | 1.75 | 3.69 | 1.81 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17